188 related articles for article (PubMed ID: 23565238)
1. CG0009, a novel glycogen synthase kinase 3 inhibitor, induces cell death through cyclin D1 depletion in breast cancer cells.
Kim HM; Kim CS; Lee JH; Jang SJ; Hwang JJ; Ro S; Choi J
PLoS One; 2013; 8(4):e60383. PubMed ID: 23565238
[TBL] [Abstract][Full Text] [Related]
2. Role of glycogen synthase kinase 3beta in rapamycin-mediated cell cycle regulation and chemosensitivity.
Dong J; Peng J; Zhang H; Mondesire WH; Jian W; Mills GB; Hung MC; Meric-Bernstam F
Cancer Res; 2005 Mar; 65(5):1961-72. PubMed ID: 15753396
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of GSK-3beta ameliorates hepatic ischemia-reperfusion injury through GSK-3beta/beta-catenin signaling pathway in mice.
Xia YX; Lu L; Wu ZS; Pu LY; Sun BC; Wang XH
Hepatobiliary Pancreat Dis Int; 2012 Jun; 11(3):278-84. PubMed ID: 22672822
[TBL] [Abstract][Full Text] [Related]
4. Biphasic dose-dependent effect of lithium chloride on survival of human hormone-dependent breast cancer cells (MCF-7).
Suganthi M; Sangeetha G; Gayathri G; Ravi Sankar B
Biol Trace Elem Res; 2012 Dec; 150(1-3):477-86. PubMed ID: 23054864
[TBL] [Abstract][Full Text] [Related]
5. GSK3 inhibitors regulate MYCN mRNA levels and reduce neuroblastoma cell viability through multiple mechanisms, including p53 and Wnt signaling.
Duffy DJ; Krstic A; Schwarzl T; Higgins DG; Kolch W
Mol Cancer Ther; 2014 Feb; 13(2):454-67. PubMed ID: 24282277
[TBL] [Abstract][Full Text] [Related]
6. Maintaining glycogen synthase kinase-3 activity is critical for mTOR kinase inhibitors to inhibit cancer cell growth.
Koo J; Yue P; Gal AA; Khuri FR; Sun SY
Cancer Res; 2014 May; 74(9):2555-68. PubMed ID: 24626091
[TBL] [Abstract][Full Text] [Related]
7. Inactivation of glycogen synthase kinase-3beta, a downstream target of the raf-1 pathway, is associated with growth suppression in medullary thyroid cancer cells.
Kunnimalaiyaan M; Vaccaro AM; Ndiaye MA; Chen H
Mol Cancer Ther; 2007 Mar; 6(3):1151-8. PubMed ID: 17363508
[TBL] [Abstract][Full Text] [Related]
8. Adiponectin modulates the glycogen synthase kinase-3beta/beta-catenin signaling pathway and attenuates mammary tumorigenesis of MDA-MB-231 cells in nude mice.
Wang Y; Lam JB; Lam KS; Liu J; Lam MC; Hoo RL; Wu D; Cooper GJ; Xu A
Cancer Res; 2006 Dec; 66(23):11462-70. PubMed ID: 17145894
[TBL] [Abstract][Full Text] [Related]
9. The Glycogen Synthase Kinase 3α and β Isoforms Differentially Regulates Interleukin-12p40 Expression in Endothelial Cells Stimulated with Peptidoglycan from Staphylococcus aureus.
Cortés-Vieyra R; Silva-García O; Oviedo-Boyso J; Huante-Mendoza A; Bravo-Patiño A; Valdez-Alarcón JJ; Finlay BB; Baizabal-Aguirre VM
PLoS One; 2015; 10(7):e0132867. PubMed ID: 26200352
[TBL] [Abstract][Full Text] [Related]
10. Targeting of GSK3β promotes imatinib-mediated apoptosis in quiescent CD34+ chronic myeloid leukemia progenitors, preserving normal stem cells.
Reddiconto G; Toto C; Palamà I; De Leo S; de Luca E; De Matteis S; Dini L; Passerini CG; Di Renzo N; Maffia M; Coluccia AM
Blood; 2012 Mar; 119(10):2335-45. PubMed ID: 22262776
[TBL] [Abstract][Full Text] [Related]
11. Fangchinoline inhibits cell proliferation via Akt/GSK-3beta/ cyclin D1 signaling and induces apoptosis in MDA-MB-231 breast cancer cells.
Wang CD; Yuan CF; Bu YQ; Wu XM; Wan JY; Zhang L; Hu N; Liu XJ; Zu Y; Liu GL; Song FZ
Asian Pac J Cancer Prev; 2014; 15(2):769-73. PubMed ID: 24568493
[TBL] [Abstract][Full Text] [Related]
12. [Effects of glycogen synthase kinase 3β overexpression in rat and glycogen synthase kinase 3β inhibitor SB-216763 on proliferation of hepatic oval cells].
Zhong JQ; Xie YK; Ji XK; Fu JH; Wang Y; Zhang QY; Shi HQ; Shan YF
Zhonghua Wai Ke Za Zhi; 2012 Nov; 50(11):1003-6. PubMed ID: 23302485
[TBL] [Abstract][Full Text] [Related]
13. Tumor-suppressive effects of psoriasin (S100A7) are mediated through the β-catenin/T cell factor 4 protein pathway in estrogen receptor-positive breast cancer cells.
Deol YS; Nasser MW; Yu L; Zou X; Ganju RK
J Biol Chem; 2011 Dec; 286(52):44845-54. PubMed ID: 22016394
[TBL] [Abstract][Full Text] [Related]
14. Prodigiosin inhibits Wnt/β-catenin signaling and exerts anticancer activity in breast cancer cells.
Wang Z; Li B; Zhou L; Yu S; Su Z; Song J; Sun Q; Sha O; Wang X; Jiang W; Willert K; Wei L; Carson DA; Lu D
Proc Natl Acad Sci U S A; 2016 Nov; 113(46):13150-13155. PubMed ID: 27799526
[TBL] [Abstract][Full Text] [Related]
15. Advanced glycation end-product-inhibited cell proliferation and protein expression of beta-catenin and cyclin D1 are dependent on glycogen synthase kinase 3beta in LLC-PK1 cells.
Lin KH; Guh JY; Mo JF; Chiou SJ; Hwang CC; Chuang LY
Arch Biochem Biophys; 2008 Sep; 477(1):27-32. PubMed ID: 18474214
[TBL] [Abstract][Full Text] [Related]
16. Enhancing Beta-Catenin Activity via GSK3beta Inhibition Protects PC12 Cells against Rotenone Toxicity through Nurr1 Induction.
Zhang L; Cen L; Qu S; Wei L; Mo M; Feng J; Sun C; Xiao Y; Luo Q; Li S; Yang X; Xu P
PLoS One; 2016; 11(4):e0152931. PubMed ID: 27045591
[TBL] [Abstract][Full Text] [Related]
17. Ursolic acid from Oldenlandia diffusa induces apoptosis via activation of caspases and phosphorylation of glycogen synthase kinase 3 beta in SK-OV-3 ovarian cancer cells.
Song YH; Jeong SJ; Kwon HY; Kim B; Kim SH; Yoo DY
Biol Pharm Bull; 2012; 35(7):1022-8. PubMed ID: 22791147
[TBL] [Abstract][Full Text] [Related]
18. Glycogen synthase kinase 3 involvement in the excessive proinflammatory response to LPS in patients with decompensated cirrhosis.
Coant N; Simon-Rudler M; Gustot T; Fasseu M; Gandoura S; Ragot K; Abdel-Razek W; Thabut D; Lettéron P; Ogier-Denis E; Ouziel R; Devière J; Lizard G; Tellier Z; Lebrec D; Moreau R
J Hepatol; 2011 Oct; 55(4):784-93. PubMed ID: 21334395
[TBL] [Abstract][Full Text] [Related]
19. GSK3 promotes arsenite-induced apoptosis via facilitation of mitochondria disruption.
Watcharasit P; Thiantanawat A; Satayavivad J
J Appl Toxicol; 2008 May; 28(4):466-74. PubMed ID: 17849503
[TBL] [Abstract][Full Text] [Related]
20. Regulation of Akt mRNA and protein levels by glycogen synthase kinase-3beta in adrenal chromaffin cells: effects of LiCl and SB216763.
Nemoto T; Kanai T; Yanagita T; Satoh S; Maruta T; Yoshikawa N; Kobayashi H; Wada A
Eur J Pharmacol; 2008 May; 586(1-3):82-9. PubMed ID: 18395711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
